Evolent Health (EVH) Operating Leases (2019 - 2026)

Evolent Health has reported Operating Leases for 8 years, with the latest figure at $4.0 million in Q2 2026.

• On a quarterly basis, Operating Leases fell 87.84% year-over-year to $4.0 million in Q2 2026; TTM through Jun 2026 was $4.0 million, a 87.84% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 84.71% from the prior year.
• Operating Leases was $4.0 million for Q2 2026 at Evolent Health, down from $11.9 million in the prior quarter.
• The five-year high for Operating Leases was $65.0 million in Q2 2022, with the low at $3.8 million in Q4 2025.
• Average Operating Leases over 5 years is $40.5 million, with a median of $41.6 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Operating Leases advanced 12.41% in 2025, then tumbled 87.84% in 2026.
• Over 5 years, Operating Leases stood at $56.0 million in 2022, then sank by 32.14% to $38.0 million in 2023, then tumbled by 34.31% to $25.0 million in 2024, then sank by 84.71% to $3.8 million in 2025, then grew by 3.9% to $4.0 million in 2026.
• The last three Operating Leases figures came in at $4.0 million (Q2 2026), $11.9 million (Q1 2026), and $3.8 million (Q4 2025), per Business Quant data.